Articularis Healthcare

To Our Members and Partners, American Rheumatology Network (ARN) and Articularis Healthcare Group Inc., (AHG) stands with the rheumatology community, with the Coalition of State Rheumatology Organizations (CSRO), and with the National Organization of Rheumatology Management (NORM) in firm opposition to the CMS “Most Favored Nation Model.” This model poses an immediate threat to patient …

ARN & AHG Position Statement: “Most Favored Nation Model” Read More »

Each patient is unique. What if their treatment path was too? That possibility is at the core of precision medicine. J. Eugene Huffstutter, MD Precision medicine allows patients to receive treatment based on their personal, genetic makeup. It is commonly associated with oncology, where therapies can address patients’ genetic biomarkers rather than just the location …

Affiliate AHG Physician Publishes “Precision Medicine: Redefining Care for Rheumatoid Arthritis” Read More »

The American Rheumatology Network (ARN) has been so successful with cost management, particularly via the use of biosimilars, that it believes its model is worthy of emulation, said Colin C. Edgerton, MD, executive chairman of ARN, who spoke on the subject recently in an Academy of Managed Care Pharmacy–sponsored webinar. “Certainly, rheumatologists are eager to …

AHG Physician Featured in: American Rheumatology Network Promotes a Biosimilar Pathway Read More »

by Colin Edgerton We are seeing COVID-19 cases peak in many areas of the US, prompting thoughts about what comes next for rheumatology practices. Many community rheumatology practices have been hit hard by the crisis, and we hope that sharing “lessons learned” will inform practices on what steps to take now, and what to anticipate …

Weathering the Storm: A Successful Rheumatology Practice During the COVID Crisis Read More »

Originally published in The Rheumatologist The Centers for Medicare & Medicaid Services (CMS) Physician Fee Schedule final rule for 2020 includes a big win for rheumatologists—a 15% increase in reimbursement for evaluation and management (E/M) services. This decision represents an historic hike in payment for these codes and resulted from 10 years of advocacy work …

AHG Physician Featured: 15% E/M Services Reimbursement Hike a Win for Rheumatology Read More »

Originally published in Biosimilar Development In the first installment of this four-part series, the members of the Biosimilar Development Editorial Board and friends discussed how 2019 turned out for the biosimilar industry. But as we face 2020, several big questions remain from the past year and about what the future may (or may not) bring …

AHG Physician Featured: What Does 2020 Hold for Biosimilars? Industry Experts Weigh In Read More »

Originally published in Biosimilar Development As we close out another year of global biosimilar successes and twists and turns, it’s always important to take stock on just how far we have come and where we still hope to go as an industry. As in years past, I reached out to members of Biosimilar Development’s editorial …

AHG Physician Featured: Biosimilar Industry Experts Highlight Triumphs, Tribulations Read More »

Originally published in The Rheumatologist For patients responsible for out-of-pocket costs associated with high-deductible health insurance plans, the financial burden associated with rheumatologic care can become overwhelming. Meanwhile, collecting payments for services is critical for a rheumatology practice to stay in the black. As a rheumatologist working in a private practice in North Charleston, S.C., …

AHG Physician Featured in Recent Article: 3 Tips for Financial Discussions with Patients Read More »

WASHINGTON, Nov. 12, 2019 /PRNewswire/ — Trio Health, a leading provider of real-world evidence, announced results from a study recently presented at the Annual Meeting of the American College of Rheumatology. ”The perception is that patients with rheumatoid arthritis, who also have comorbidities, have higher costs of their RA-related care compared to patients without any comorbidities,” said Janna …

AHG Physician Featured in Recent Article: Trio Health Reports on Outpatient Costs for Individuals with Rheumatoid Arthritis (RA) Treated in the U.S. Community Practices Read More »

Originally published in Rheumatology Network The price of a medication can be a significant factor in poor adherence to treatment, and few other specialties have higher medication prices than rheumatology. How can rheumatologists help their patients navigate the system so that they can get the best medication at the best price? In the current U.S. …

AHG Physician Featured In Recent Article: Paying for Rheumatology Care is Complex Read More »